qNMR spectroscopy

Assay determination (small molecules, phospholipids, impurities, poloxamers)

Therapeutic Modalities:

Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

non-GMP (ISO 9001:2015) (internal) and GMP (Spectralservice)

Pharmacopoeia:

EP 2.02.33, EP 1464, EP 1804; USP: Monograph: poloxamers; USP: Monograph: Hydroxypropyl Betadex